A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 3029-3038

  Liu, Li Qin ^a   Ilaria Jr , Robert ^a,d   Kingsley, Paul D ^b   Iwama, Atsushi ^a   Van Etten, Richard A ^a   Palis, James ^b   Zhang, Dong Er ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PROTEIN UBP43; PROTEINASE; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; EMBRYO; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE OVEREXPRESSION; GENE TRANSFER; HEMATOPOIETIC CELL; LEUKEMIA; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALIA; MURINAE; RODENTIA;

EID: 0032934989     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.3029     Document Type: Article

References (55)

1. Chau, V., J. W. Tobias, A. Bachmair, D. Marriott, D. J. Ecker, D. K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243:1576-1583.
2. Chen, P., P. Johnson, T. Sommer, S. Jentsch, and M. Hochstrasser. 1993. Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell 74:357-369.
3. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
4. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
5. Chowdary, D. R., J. J. Dermody, K. K. Jha, and H. L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14:1997-2003.
6. D'Andrea, A., and D. Pellman. 1998. Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33:337-352.
7. Davie, J. R., and L. C. Murphy. 1990. Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry 29:4752-4757.
8. Fackler, M. J., D. S. Krause, O. M. Smith, C. I. Civin, and W. S. May. 1995. Full-lenglh but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040-3047.
9. Fischer-Vize, J. A., G. M. Rubin, and R. Lehmann. 1992. The fat facets gene is required for Drosophila eye and embryo development. Development 116: 985-1000.
10. Frank, R., J. Zhang, H. Uchida, S. Meyers, S. W. Hiebert, and S. D. Nimer. 1995. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11:2667-2674.
11. Friedman, A. D., B. L. Krieder, D. Venturelli, and G. Rovera. 1991. Transcriptional regulation of two myeloid-specific genes, myeloperoxidase and lactoferrin, during differentiation of the murine cell line 32D C13. Blood 78: 2426-2432.
12. Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349:132-138.
13. Goldstein, G., M. Scheid, U. Hammerling, D. H. Schlesinger, H. D. Niall, and E. A. Boyse. 1975. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA 72:11-15.
14. Gordon, S., S. Keshav, and L. P. Chung. 1988. Mononuclear phagocytes: tissue distribution and functional heterogeneity. Curr. Opin. Immunol. 1:26-35.
15. Gupta, K., M. Chevrette, and D. A. Gray. 1994. The Unp proto-oncogene encodes a nuclear protein. Oncogene 9:1729-1731.
16. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
17. Hershko, A., and A. Ciechanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761-807.
18. Hetherington, C. J., N. Harakawa, D. A. Yergeau, L.-Q. Liu, D. G. Tenen, and D. E. Zhang. Inducible AML1-ETO expression in transgenic mice. Submitted for publication.
19. Hicke, L., and H. Riezman. 1996. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulaled endocytosis. Cell 84:277-287.
20. Hochstrasser, M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405-439.
21. Hoffman-Liebermann, B., and D. A. Liebermann. 1991. Interleukin-6-and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol. 11:2375-2381.
22. Huang, Y., R. T. Baker, and J. A. Fischer-Vize. 1995. Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science 270:1828-1831.
23. Hubank, M., and D. G. Schatz. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:5640-5648.
24. Ichikawa, Y. 1970. Further studies on the differentiation of a cell line of myeloid leukemia. J. Cell Physiol. 76:175-184.
25. King, R. W., R. J. Deshaies, J. M. Peters, and M. W. Kirschner. 1996. How proteolysis drives the cell cycle. Science 274:1652-1659.
26. Klampfer, L., J. Zhang, A. O. Zelenetz, H. Uchida, and S. D. Nimer. 1996. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA 93:14059-14064.
27. Larsen, C. N., J. S. Price, and K. D. Wilkinson. 1996. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 35:6735-6744.
28. Lerner, A., L. K. Clayton, E. Mizoguchi, Y. Ghendler, E. W. Van, S. Koyasu, A. K. Bhan, and E. L. Reinherz. 1996. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J. 15:5876-5887.
29. Levinger, L., and A. Varshavsky. 1982. Selective arrangement of ubiquitinated and D1 protein-containing nucleosomes within the Drosophila genome. Cell 28:375-385.
30. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
31. Meyers, S., N. Lenny, and S. W. Hiebert. 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15:1974-1982.
32. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-986, 989.
33. Moazed, D., and D. Johnson. 1996. A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S. cerevisiae. Cell 86:667-677.
34. Okuda, T., Z. Cai, S. Yang, N. Lenny, C. Lyu, D. J. Van, H. Harada, and J. R. Downing. 1998. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91:3134-3143.
35. Okuda, T., D. J. Van, S. W. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
36. Onno, M., T. Nakamura, R. Mariage-Samson, J. Hillova, and M. Hill. 1993. Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes. DNA Cell Biol. 12:107-118.
37. Palis, J., and H. D. Kingsley. 1995. Differential gene expression during early murine yolk sac development. Mol. Reprod. Dev. 42:19-27.
38. Papa, F. R., and M. Hochstrasser. 1993. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366:313-319.
39. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
40. Rhoades, K. L., C. J. Hetherington, J. D. Rowley, S. W. Hiebert, G. Nucifora, D. G. Tenen, and D. E. Zhang. 1996. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA 93:11895-11900.
41. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
42. Rowley, J. D. 1990. Recurring chromosome abnormalities in leukemia and lymphoma. Semin. Hematol. 27:122-136.
43. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
44. Svedberg, H., K. Chylicki, B. Baldetorp, F. J. Rauscher, and U. Gullberg. 1998. Constitutive expression of the Wilm's tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 16:925-932.
45. Tobias, J. W., and A. Varshavsky. 1991. Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae. J. Biol. Chem. 266:12021-12028.
46. Valtieri, M., D. J. Tweardy, D. Caracciolo, K. Johnson, F. Mavilio, S. Altmann, D. Santoli, and G. Rovera. 1987. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 138:3829-3835.
47. Vassilev, A. P., H. H. Rasmussen, E. I. Christensen, S. Nielsen, and J. E. Celis. 1995. The levels of ubiquitinated histone H2A are highly upregulated in transformed human cells: partial colocalization of uH2A clusters and PCNA/cyclin foci in a fraction of cells in S-phase. J. Cell Sci. 108:1205-1215.
48. Verma, I. M., J. K. Stevenson, E. M. Schwartz, A. D. Van, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
49. Wang, Q., T. Stacy, M. Binder, M. Mann-Padilla, A. H. Sharpe, and N. A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93:3444-3449.
50. Wang, Y., Y. G. Yeung, W. Y. Langdon, and E. R. Stanley. 1996. c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 271:17-20.
51. Wilkinson, K. D., V. L. Tashayev, L. B. O'Connor, C. N. Larsen, E. Kasperek, and C. M. Pickart. 1995. Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry 34: 14535-14546.
52. Cdc28-mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15:731-741.
53. Yergeau, D. A., C. J. Hetherington, Q. Wang, P. Zhang, A. H. Sharpe, M. Binder, M. Marin-Padilla, D. G. Tenen, N. A. Speck, and D. E. Zhang. 1997. Embryonic lethality and impairment of haemotopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15:303-306.
54. Zhu, Y., M. Caroll, F. R. Papa, M. Hochstrasser, and A. D. D'Andrea. 1996. DUB-1, a deubiquitinating enzyme with growth-suppressing activity. Proc. Natl. Acad. Sci. USA 93:3275-3279.
55. Zhu, Y., K. Lambert, C. Corless, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. D. D'Andrea. 1997. DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. J. Biol. Chem. 272:51-57.